Big Purple Dragon (Cannabis flos PhytoPur Bio): lineage of Purple Urkle and Dragon's Breath

Where does Big Purple Dragon come from and what does its lineage say about it?

Big Purple Dragon is a hybrid resulting from the crossbreeding of Purple Urkle with Dragon's Breath. The lineage is provided by two independent descriptions of the strain, one of which directly refers to the pharmaceutical version from PhytoPur Bio. Both sources also agree on the type of plant, so the designation hybrid is not a guess here.

However, the lineage says less than the name would suggest. The record of the cross describes the origin of the seed material, not the chemical composition of the offspring: under the same parent combination, there are usually several lines selected separately by different breeders, and each of them yields a different result in batch testing. Therefore, knowing the parents organizes the genealogy and nothing more.

The sources of this information need to be named. Both lineage indications are market descriptions, one general and one directly related to the PhytoPur Bio product, and not the registration documentation of the drug. In the documents allowing the dried flower to be marketed, the parent of the plant does not appear, as it is not a quality parameter of the raw material.

In the context of the entire overview, this strain performs well. The origin has been established for 60 out of 85 described cultivars, while for the remaining 25, there is none at all, because the breeder never disclosed it or the available descriptions contradict each other. The declared THC content ranges from 21.6% to 26.4%, given as a range because the permissible deviation from the label value reaches one-tenth of the declaration, and each batch is tested separately.

Who supplies this strain to Polish pharmacies?

One supplier. In the collected overview, Big Purple Dragon appears exclusively in the version from PhytoPur Bio, so there is nothing to compare between manufacturers: there is no second pharmaceutical version of the same name. The current availability status along with prices is listed in the collective overview of strains, not here.

One supplier also means one cultivation method. With names run concurrently by two companies, it is possible to compare batch test results and see how the same genetics diverges in the hands of different manufacturers. Here, such a comparison cannot be made, and the description prepared by the producer remains the only description of this strain available to Polish patients.

The list of suppliers is not permanent. Dried flower reaches pharmacies in batches, and a break in import or withdrawal of a series can remove a name from circulation for many weeks and restore it later, sometimes with a noticeably different test result. The record of a single producer describes the moment when this overview was created, not a permanent property of the strain.

Access to this entry is determined by a prescription, not by stock status. Dried hemp is issued solely by a doctor's prescription in category Rpw. The remaining entries from this producer opisujemy osobno, and we maintain a list of everything that can currently be fulfilled in the pharmacy in a comprehensive overview of strains.

What does Big Purple Dragon smell and taste like?

No one has measured the aroma of this strain. What can be said comes from the profile composition provided by one source: caryophyllene, humulene, linalool, and myrcene. These molecules have recognizable notes, so the direction of the aroma can be described, but the specific smell of the batch remains a matter of personal perception.

Caryophyllene is the same molecule responsible for the sharp note of black pepper. It leads the profile, so the overall experience is often described as spicy, with a distinct woody background, closer to resinous heaviness than citrus brightness. Humulene, also present in hop cones, adds an earthy tone and a slight bitterness.

Linalool brings a floral note known from lavender, while myrcene adds an herbal and slightly musky tone. The presence of these four molecules together explains why strain descriptions rarely hit on sweetness, even though the name itself might suggest it.

This description has a clear boundary. Neither the smell nor the taste of this strain has been tested under controlled conditions, and what one person perceives depends on the vaporizer temperature, the humidity of the dried flower, and their own sensitivity threshold. The aroma does not predict the effect: the connection between smell and effect is a guess, not a determination.

After how long does the effect appear and how long does it last?

The method of administration determines the outcome more than the strain name. When inhaling vapor, the effect builds up within a few minutes and ends the same day; when swallowed, it starts with a noticeable delay and lasts much longer. The time frames given below pertain to the physiology of absorption, not this specific cultivar.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For Big Purple Dragon itself, there is no such measurement, and one should not expect it. Pharmacokinetic studies are conducted for preparations with a fixed, repeatable composition, not for commercial names of dried flower, whose test results change between batches.

What has been studied in relation to this strain, and what has not?

The same strain has not been studied. Published works focus on caryophyllene, a single molecule present in its profile, and were conducted on mice and in vitro. Everything beyond that comes from patient reports or marketing materials and does not have the status of evidence.

The first was signed by the Gertsch team and published in 2008 in the journal PNAS (PMID:18574142). The authors showed that (E)-caryophyllene selectively binds to the CB2 receptor, and the response induced by carrageenan weakened in wild-type mice, while in animals lacking this receptor, it did not diminish at all. No anxiety test was conducted in this study.

The second, dedicated to pain, was prepared by the Klauke team and published in European Neuropsychopharmacology in 2014 (PMID:24210682). Caryophyllene administered orally suppressed the second, inflammatory phase of the formalin response in mice, with suppression disappearing in animals without the CB2 receptor, while the early phase remained unaffected. In neuropathic pain, animals responded less to thermal stimuli and touch, and prolonged administration did not lead to tolerance.

Neither of the two studies tested caryophyllene on humans or in inhaled form from dried flower; both studies pertain to oral or systemic administration in mice in pain and inflammation models, not sleep or mood.

The rest of what is said about this strain is not evidence. Descriptions of effects circulating on forums and in marketing materials are reports from individual people, collected without a control group and without blinding, so it is impossible to separate the effects of the raw material from expectations.

We know the profile composition from one database, budcare.pl, which lists alongside kariofilenu humulene, linalool and myrcene.

We do not provide percentage shares. The total shares published by Polish databases for the same items vary, sometimes at 46%, sometimes 73%, sometimes 83%, so the denominator is different in each comparison, and the numbers from two tables cannot be compared.

What undesirable symptoms are described after using this type of dried flower?

There are no separate reports for this name. Big Purple Dragon is supplied by one company, and even with more widely available cultivars, symptom compilations are not broken down by strain. The following description therefore pertains to hemp flower as a group of raw materials and is common to all items in this compilation.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

The assessment of whether this dried flower can be reconciled with the rest of the treatment belongs to the prescribing physician and the pharmacist, as it requires insight into the full list of medications taken, not just the description of the plant.

At what temperature should this dried flower be vaporized?

There is no single correct value. Caryophyllene, the leading molecule in this profile, evaporates at a higher range than lighter terpenes, so low settings will leave it in the dried flower. However, the temperature tables can be inconsistent with each other and measure something different than what happens in the chamber.

The number on the display is not the temperature of the dried flower. The heater measures itself or the air right next to it, and the material in the chamber can be cooler by several dozen degrees, depending on the device's construction, chamber packing, and the rate of inhalation. The same setting on two vaporizers does not therefore mean the same state of the raw material.

The temperature tables for terpene evaporation also contradict each other. Published values come from measurements taken at different pressures and for pure substances, not for a mixture settled on plant material, so transferring them directly to the device's setting is an oversimplification. The scale of these discrepancies opisujemy osobno.

A practical conclusion for this profile should be made cautiously. Lighter molecules are released earlier and they build the first puff, while caryophyllene along with humulene evaporates later, so setting from the lower end of the scale impoverishes the aroma of that part of the profile. How these thresholds are distributed, we show in the context of terpene evaporation.

Does Big Purple Dragon have siblings available in Polish pharmacies?

There are none. In the pedigree graph of this comparison, no other cultivar available in Polish pharmacies shares both parents with it or even one identified parent. An empty list is not a gap in the data, but a result: Purple Urkle and Dragon's Breath do not appear in the pedigrees of the other described strains.

An empty sibling list can also be a correct result even with a known pedigree. The field for related strains contains data for 29 out of 85 cultivars, while the rest remains empty partly because the parent may be a landrace or a broad family style, such as afghani or haze. These are categories, not individual identified strains, so two cultivars sharing only such an ancestor are not considered siblings.

Association by name does not work here either. A common element with another strain does not prove anything in either direction: in this compilation, the word kush is associated with ten cultivars, five of which have an established pedigree, and five do not have one at all. Big Purple Dragon shares a name component with several other market positions, and this also says nothing about kinship.

Strains with a similar profile composition can, however, be found differently, through the leading terpene. We describe the compilation of cultivars where caryophyllene leads separately, and we maintain a complete list of items available in Polish pharmacies. a comprehensive overview of strains.

Frequently Asked Questions about Big Purple Dragon

Is Big Purple Dragon available in Polish pharmacies?

Yes, in the compiled summary, it is provided by one company, PhytoPur Bio. Dried flower is issued exclusively with a doctor's prescription in the Rpw category, and the availability of individual items changes with deliveries, so the current status is checked in the collective summary of strains, not in the strain description.

Which terpene leads in the profile of this strain?

Caryophyllene. The profile composition is provided by one database, budcare.pl, listing alongside it humulene, linalool, and myrcene. We do not provide percentage shares because the sources do not disclose the denominator against which they are calculated.

What is the THC content in Big Purple Dragon?

The declared content ranges from 21.6% to 26.4%. We provide it as a range, not a single number, because the allowable deviation from the label value reaches one-tenth of the declaration, and each batch of dried flower is tested separately.

Is Big Purple Dragon an indica or sativa?

Available descriptions consistently classify it as a hybrid. The division into indica and sativa primarily refers to the plant's morphology and its geographical origin, not to how the dried flower will affect a specific patient.

Has it been shown that this strain has analgesic effects?

No. Two studies that can be referenced here concern caryophyllene administered to mice, not this strain or the dried flower in inhalable form. Transferring their results to humans would be an overinterpretation, not a conclusion.

Does Big Purple Dragon have siblings among pharmaceutical strains?

No. No other cultivar described in this summary shares an identified parent with it, so the field for related strains remains empty. This is not a lack of data, but a result of searching the pedigree graph.

Dried flower is a pharmaceutical raw material issued with a doctor's prescription in the Rpw category. The above text is for informational purposes, describes the state of available data, and does not replace medical or pharmaceutical advice.

Author: ubocha